# Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin

> **NCT07699276** · PHASE2 · RECRUITING · sponsor: **Mahidol University** · enrollment: 95 (estimated)

## Conditions studied

- Cancer (Solid Tumors)
- Vomiting
- Cisplatin
- Olanzapine

## Interventions

- **DRUG:** dexamethasone sparing

## Key facts

- **NCT ID:** NCT07699276
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-11-15
- **Target enrollment:** 95 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699276, "Steroid Sparing Regimen With Olanzapine and Palonosetron for Emetic Prevention for High Dose Cisplatin". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*